New paradigms in cAMP signalling

Molecular and Cellular Endocrinology

Volumn 353, Issue 1-2, 2012, Pages 3-9

  Antoni, Ferenc A ^a  

^a EGIS PHARMACEUTICALS LTD   (Hungary)

Author keywords

Adenylyl cyclase; Biosensor; CAMP; Phosphodiesterase; Plasticity; Signal transduction

Indexed keywords

ADENYLATE CYCLASE; ARGIPRESSIN; CALCIUM ION; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; G PROTEIN COUPLED RECEPTOR; PARATHYROID HORMONE; POTASSIUM CHANNEL; POTASSIUM CHANNEL HERG; PROTEIN KINASE C;

BIOSENSOR; CALCIUM CELL LEVEL; CELL MEMBRANE; CORTICOTROPIN RELEASE; CYTOPLASM; DENDRITE; ENDOCYTOSIS; ENDOSOME; HOMEOSTASIS; HUMAN; HUMAN GENOME; HYPERPOLARIZATION; HYPOPHYSIS; INTRACELLULAR SIGNALING; INTRACELLULAR TRANSPORT; NERVE CELL PLASTICITY; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; RNA INTERFERENCE;

ADENYLATE CYCLASE; ANIMALS; CYCLIC AMP; DENDRITES; GENOME, HUMAN; GTP-BINDING PROTEINS; HUMANS; INSECTS; MULTIENZYME COMPLEXES; SECOND MESSENGER SYSTEMS;

EID: 84857784366     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.10.034     Document Type: Review

References (87)

1. Allen J.A., Halverson-Tamboli R.A., Rasenick M.M. Lipid raft microdomains and neurotransmitter signalling. Nat. Rev. Neurosci. 2007, 8:128-140.
2. Ang K.L., Antoni F.A. Functional plasticity of cyclic AMP hydrolysis in rat adenohypophyseal corticotroph cells. Cell. Signal. 2002, 14:445-452.
3. Antoni F.A. Hypothalamic regulation of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr. Rev. 1986, 7:351-378.
4. Antoni F.A. Vasopressinergic control of anterior pituitary adrenocorticotropin secretion comes of age. Front. Neuroendocrinol. 1993, 14:76-122.
5. Antoni F.A. Calcium checks cyclic AMP - mechanism of corticosteroid feedback in adenohypophysial corticotrophs. J. Neuroendocrinol. 1996, 8:659-672.
6. Antoni F.A. Molecular diversity of cyclic AMP signaling. Front. Neuroendocrinol. 2000, 21:103-132.
7. Antoni F.A., Barnard R.J.O., Shipston M.J., Smith S.M., Simpson J., Paterson J.M. Calcineurin feedback inhibition of agonist-evoked cAMP formation. J. Biol. Chem. 1995, 270:28055-28061.
8. + channels reverses the inhibition of secretagogue stimulated ACTH release by atriopeptin. J. Endocrinol. 1990, 126:183-191.
9. Antoni F.A., Sosunov A.A., Haunso A., Paterson J.M., Simpson J. Short-term plasticity of cyclic adenosine 3',5'-monophosphate signaling in anterior pituitary corticotrope cells: the role of adenylyl cyclase isotypes. Mol. Endocrinol. 2003, 17:692-703.
10. Antoni F.A., Wiegand U.K., Black J., Simpson J. Cellular localisation of adenylyl cyclase: a post-genome perspective. Neurochem. Res. 2006, 31:287-295.
11. Bacskai B.J., Hochner B., Mahaut-Smith M., Adams S.R., Kaang B.K., Kandel E.R., Tsien R.Y. Spatially resolved dynamics of cAMP and protein kinase A subunits in Aplysia sensory neurons. Science 1993, 260:222-226.
12. Berridge M.J. Neuronal calcium signaling. Neuron 1998, 21:13-26.
13. Bilezikjian L.M., Blount A.L., Vale W.W. The cellular actions of vasopressin on corticotrophs of the anterior pituitary: resistance to glucocorticoid action. Mol. Endocrinol. 1987, 1:451-458.
14. Buck J., Levin L.R. Physiological sensing of carbon dioxide/bicarbonate/pH via cyclic nucleotide signaling. Sensors Basel Sensors 2011, 11:2112-2128.
15. Calebiro D., Nikolaev V.O., Gagliani M.C., de Filippis T., Dees C., Tacchetti C., Persani L., Lohse M.J. Persistent cAMP-signals triggered by internalized G-protein-coupled receptors. PLoS Biol. 2009, 7:e1000172.
16. Calebiro D., Nikolaev V.O., Lohse M.J. Imaging of persistent cAMP signaling by internalized G protein-coupled receptors. J. Mol. Endocrinol. 2010, 45:1-8.
17. Calebiro D., Nikolaev V.O., Persani L., Lohse M.J. Signaling by internalized G-protein-coupled receptors. Trends Pharmacol. Sci. 2010, 31:221-228.
18. Carvallo P., Aguilera G. Protein kinase C mediates the effect of vasopressin in pituitary corticotrophs. Mol. Endocrinol. 1989, 3:1935-1943.
19. Chou J.L., Huang C.L., Lai H.L., Hung A.C., Chien C.L., Kao Y.Y., Chern Y. Regulation of type VI adenylyl cyclase by Snapin, a SNAP25-binding protein. J. Biol. Chem. 2004, 279:46271-46279.
20. Chowdrey H.S., Larsen P.J., Harbuz M.S., Jessop D.S., Aguilera G., Eckland D.J., Lightman S.L. Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis. Br. J. Pharmacol. 1995, 116:2417-2424.
21. Conti M., Beavo J. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu. Rev. Biochem. 2007, 76:481-511.
22. Crossthwaite A.J., Seebacher T., Masada N., Ciruela A., Dufraux K., Schultz J.E., Cooper D.M. The cytosolic domains of Ca2+-sensitive adenylyl cyclases dictate their targeting to plasma membrane lipid rafts. J. Biol. Chem. 2005, 280:6380-6391.
23. Dallman M.F., Akana S.F., Scribner K., Bradbury M.J., Walker C.-D., Strack A.M., Cascio C.S. Stress, feedback and facilitation on the hypothalamo-pituitary-adrenal axis. J. Neuroendocrinol. 1992, 4:517-526.
24. Denker S.P., McCaffery J.M., Palade G.E., Insel P.A., Farquhar M.G. Differential distribution of alpha subunits and beta gamma subunits of heterotrimeric G proteins on Golgi membranes of the exocrine pancreas. J. Cell Biol. 1996, 133:1027-1040.
25. Dessauer C.W. Adenylyl cyclase - A-kinase anchoring protein complexes: the next dimension in cAMP signaling. Mol. Pharmacol. 2009, 76:935-941.
26. Deuster P.A., Petrides J.S., Singh A., Lucci E.B., Chrousos G.P., Gold P.W. High intensity exercise promotes escape of adrenocorticotropin and cortisol from suppression by dexamethasone: sexually dimorphic responses. J. Clin. Endocrinol. Metab. 1998, 83:3332-3338.
27. Dodge K.L., Khouangsathiene S., Kapiloff M.S., Mouton R., Hill E.V., Houslay M.D., Langeberg L.K., Scott J.D. MAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J. 2001, 20:1921-1930.
28. Ferguson G.D., Storm D.R. Why calcium-stimulated adenylyl cyclases?. Physiology (Bethesda) 2004, 19:271-276.
29. Ferrandon S., Feinstein T.N., Castro M., Wang B., Bouley R., Potts J.T., Gardella T.J., Vilardaga J.P. Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Nat. Chem. Biol. 2009, 5:734-742.
30. Gao T., Puri T.S., Gerhardstein B.L., Chien A.J., Green R.D., Hosey M.M. Identification and subcellular localization of the subunits of L-type calcium channels and adenylyl cyclase in cardiac myocytes. J. Biol. Chem. 1997, 272:19401-19407.
31. Gloerich M., Bos J.L. Epac: defining a new mechanism for cAMP action. Annu. Rev. Pharmacol. Toxicol. 2010, 50:355-375.
32. Head B.P., Patel H.H., Roth D.M., Lai N.C., Niesman I.R., Farquhar M.G., Insel P.A. G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes. J. Biol. Chem. 2005, 280:31036-31044.
33. Hempel C.M., Vincent P., Adams S.R., Tsien R.Y., Selverston A.I. Spatio-temporal dynamics of cyclic AMP signals in an intact neural circuit. Nature 1996, 384:166-169.
34. Hill S.J., Williams C., May L.T. Insights into GPCR pharmacology from the measurement of changes in intracellular cyclic AMP; advantages and pitfalls of differing methodologies. Br. J. Pharmacol. 2010, 161:1266-1275.
35. Holmes M.C., Antoni F.A., Aguilera G., Catt K.J. Magnocellular axons in passage through the median eminence release vasopressin. Nature 1986, 319:326-329.
36. Houslay M.D., Baillie G.S., Maurice D.H. CAMP-specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling. Circ. Res. 2007, 100:950-966.
37. Houslay M.D., Milligan G. Tailoring cAMP-signalling responses through isoform multiplicity. Trends Biochem. Sci. 1997, 22:217-224.
38. Jalink K., Moolenaar W.H. G protein-coupled receptors: the inside story. Bioessays 2010, 32:13-16.
39. Kamenetsky M., Middelhaufe S., Bank E.M., Levin L.R., Buck J., Steegborn C. Molecular details of cAMP generation in mammalian cells: a tale of two systems. J. Mol. Biol. 2006, 362:623-639.
40. Keravis T., Lugnier C. Cyclic nucleotide phosphodiesterases (PDE) and peptide motifs. Curr. Pharm. Des. 2010, 16:1114-1125.
41. Leech C.A., Chepurny O.G., Holz G.G. Epac2-dependent rap1 activation and the control of islet insulin secretion by glucagon-like peptide-1. Vitam. Horm. 2010, 84:279-302.
42. Lim M.C., Shipston M.J., Antoni F.A. Depolarisation counteracts glucocorticoid inhibition of adenohypophysial corticotroph cells. Br. J. Pharmacol. 1998, 124:1735-1743.
43. Lim M.C., Shipston M.J., Antoni F.A. Posttranslational modulation of glucocorticoid feedback inhibition at the pituitary level. Endocrinology 2002, 143:3796-3801.
44. Logue J.S., Scott J.D. Organizing signal transduction through A-kinase anchoring proteins (AKAPs). FEBS J. 2010, 277:4370-4375.
45. Ludwig M., Sabatier N., Bull P.M., Landgraf R., Dayanithi G., Leng G. Intracellular calcium stores regulate activity-dependent neuropeptide release from dendrites. Nature 2002, 418:85-89.
46. Lynch M.J., Hill E.V., Houslay M.D. Intracellular targeting of phosphodiesterase-4 underpins compartmentalized cAMP signaling. Curr. Top. Dev. Biol. 2006, 75:225-259.
47. MacPhee I.A.M., Antoni F.A., Mason D.W. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. Med. 1989, 169:431-445.
48. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., Marks A.R. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 2000, 101:365-376.
49. Mason D. Genetic variation in the stress response susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory disease. Immunol. Today 1991, 12:57-60.
50. Meijer O.C., de Lange E.C., Breimer D.D., de Boer A.G., Workel J.O., de Kloet E.R. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 1998, 139:1789-1793.
51. Mons N., Harry A., Dubourg P., Premont R.T., Iyengar R., Cooper D.M. Immunohistochemical localization of adenylyl cyclase in rat brain indicates a highly selective concentration at synapses. Proc. Natl. Acad. Sci. USA 1995, 92:8473-8477.
52. Muller L., Picart R., Barret A., Bockaert J., Homburger V., Tougard C. Identification of multiple subunits of heterotrimeric G proteins on the membrane of secretory granules in rat prolactin anterior pituitary cells. Mol. Cell. Neurosci. 1994, 5:556-566.
53. Nagy G., Reim K., Matti U., Brose N., Binz T., Rettig J., Neher E., Sorensen J.B. Regulation of releasable vesicle pool sizes by protein kinase A-dependent phosphorylation of SNAP-25. Neuron 2004, 41:417-429.
54. Nikolaev V.O., Lohse M.J. Monitoring of cAMP synthesis and degradation in living cells. Physiology (Bethesda) 2006, 21:86-92.
55. Ostrom R.S., Insel P.A. The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br. J. Pharmacol. 2004, 143:235-245.
56. Pasterkamp R.J., Verhaagen J. Semaphorins in axon regeneration: developmental guidance molecules gone wrong?. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2006, 361:1499-1511.
57. Patel T.B., Du Z.Y., Pierre S.C., Cartin L., Scholich K. Molecular biological approaches to unravel adenylyl cyclase signaling and function. Gene 2001, 269:13-25.
58. Plotsky P.M. Pathways to the secretion of adrenocorticotropin: a view from the portal. J. Neuroendocrinol. 1991, 3:1-9.
59. Pronko S.P., Saba L.M., Hoffman P.L., Tabakoff B. Type 7 adenylyl cyclase-mediated hypothalamic-pituitary-adrenal axis responsiveness: influence of ethanol and sex. J. Pharmacol. Exp. Ther. 2010, 334:44-52.
60. Ramos L.S., Zippin J.H., Kamenetsky M., Buck J., Levin L.R. Glucose and GLP-1 stimulate cAMP production via distinct adenylyl cyclases in INS-1E insulinoma cells. J. Gen. Physiol. 2008, 132:329-338.
61. Robben J.H., Kortenoeven M.L., Sze M., Yae C., Milligan G., Oorschot V.M., Klumperman J., Knoers N.V., Deen P.M. Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists. Proc. Natl. Acad. Sci. USA 2009, 106:12195-12200.
62. Rose C.R., Konnerth A. Stores not just for storage. Intracellular calcium release and synaptic plasticity. Neuron 2001, 31:519-522.
63. Sadana R., Dessauer C.W. Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies. Neurosignals 2009, 17:5-22.
64. Sakaba T., Neher E. Direct modulation of synaptic vesicle priming by GABA(B) receptor activation at a glutamatergic synapse. Nature 2003, 424:775-778.
65. Schurmann A., Rosenthal W., Schultz G., Joost H.G. Characterization of GTP-binding proteins in Golgi-associated membrane vesicles from rat adipocytes. Biochem. J. 1992, 283(Pt. 3):795-801.
66. Shipston M.J., Duncan R.R., Clark A.G., Antoni F.A., Tian L. Molecular components of large conductance calcium activated potassium (BK) channels in mouse pituitary corticotropes. Mol. Endocrinol. 1999, 13:1728-1737.
67. Shipston M.J., Hernando F., Barnard R.J.O., Antoni F.A. Glucocorticoid negative feedback in pituitary corticotropes: pivotal role for calcineurin inhibition of adenylyl cyclase. Ann. NY Acad. Sci. 1994, 746:453-455.
68. Shipston M.J., Kelly J.S., Antoni F.A. Glucocorticoids block protein kinase A inhibition of calcium-activated potassium channels. J. Biol. Chem. 1996, 271:9197-9200.
69. Sosunov S.A., Kemaikin S.P., Kurnikova I.A., Antoni F.A., Sosunov A.A. Expression of adenylyl cyclase type IX and calcineurin in synapses of the central nervous system. Bull. Exp. Biol. Med. 2001, 131:172-175.
70. Sternberg E.M., Hill J.M., Chrousos G.P., Kamilaris T., Listwak S.J., Gold P.W., Wilder R.L. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc. Natl. Acad. Sci. USA 1989, 86:2374-2378.
71. Stojilkovic S.S., Tabak J., Bertram R. Ion channels and signaling in the pituitary gland. Endocr. Rev. 2010, 31:845-915.
72. Sunahara R.K., Dessauer C.W., Whisnant R.E., Kleuss C., Gilman A.G. Interaction of Gsalpha with the cytosolic domains of mammalian adenylyl cyclase. J. Biol. Chem. 1997, 272:22265-22271.
73. (s)a and forskolin. Science 1995, 268:1769-1772.
74. Taussig R., Gilman A.G. Mammalian membrane-bound adenylyl cyclases. J. Biol. Chem. 1995, 270:1-4.
75. Taylor C.W., Tovey S.C. IP(3) receptors: toward understanding their activation. Cold Spring Harb. Perspect. Biol. 2010, 2:a004010.
76. Taylor S.S., Yang J., Wu J., Haste N.M., Radzio-Andzelm E., Anand G. PKA: a portrait of protein kinase dynamics. Biochim. Biophys. Acta 2004, 1697:259-269.
77. Thrivikraman K.V., Nemeroff C.B., Plotsky P.M. Sensitivity to glucocorticoid-mediated fast-feedback regulation of the hypothalamic-pituitary-adrenal axis is dependent upon stressor specific neurocircuitry. Brain Res. 2000, 870:87-101.
78. Tian L., Hammond M.S., Florance H., Antoni F.A., Shipston M.J. Alternative splicing determines sensitivity of murine calcium-activated potassium channels to glucocorticoids. J. Physiol. (Lond.) 2001, 537:57-68.
79. Tian L.J., Knaus H.G., Shipston M.J. Glucocorticoid regulation of calcium-activated potassium channels mediated by serine/threonine protein phosphatase. J. Biol. Chem. 1998, 273:13531-13536.
80. Wang H., Pineda V.V., Chan G.C., Wong S.T., Muglia L.J., Storm D.R. Type 8 adenylyl cyclase is targeted to excitatory synapses and required for mossy fiber long-term potentiation. J. Neurosci. 2003, 23:9710-9718.
81. Wayman G.A., Wei J., Wong S., Storm D.R. Regulation of type I adenylyl cyclase by calmodulin kinase IV in vivo. Mol. Cell. Biol. 1996, 16:6075-6082.
82. Wei J., Zhao A.Z., Chan G.C., Baker L.P., Impey S., Beavo J.A., Storm D.R. Phosphorylation and inhibition of olfactory adenylyl cyclase by CaM kinase II in Neurons: a mechanism for attenuation of olfactory signals. Neuron 1998, 21:495-504.
83. Willoughby D., Cooper D.M. Organization and Ca2+ regulation of adenylyl cyclases in cAMP microdomains. Physiol. Rev. 2007, 87:965-1010.
84. Willoughby D., Cooper D.M. Live-cell imaging of cAMP dynamics. Nat. Methods 2008, 5:29-36.
85. Wotjak C.T., Ludwig M., Ebner K., Russell J.A., Singewald N., Landgraf R., Engelmann M. Vasopressin from hypothalamic magnocellular neurons has opposite actions at the adenohypophysis and in the supraoptic nucleus on ACTH secretion. Eur. J. Neurosci. 2002, 16:477-485.
86. Yamashita M., Oki Y., Iino K., Hayashi C., Matsushita F., Faje A., Nakamura H. The role of ether-a-go-go-related gene K(+) channels in glucocorticoid inhibition of adrenocorticotropin release by rat pituitary cells. Regul. Pept. 2009, 152:73-78.
87. Zaccolo M., Pozzan T. Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 2002, 295:1711-1715.